IL160599A0 - Derivatives of c2-substituted indan-1-ol systems, processes for their preparation and their use as pharmaceuticals - Google Patents

Derivatives of c2-substituted indan-1-ol systems, processes for their preparation and their use as pharmaceuticals

Info

Publication number
IL160599A0
IL160599A0 IL16059902A IL16059902A IL160599A0 IL 160599 A0 IL160599 A0 IL 160599A0 IL 16059902 A IL16059902 A IL 16059902A IL 16059902 A IL16059902 A IL 16059902A IL 160599 A0 IL160599 A0 IL 160599A0
Authority
IL
Israel
Prior art keywords
pharmaceuticals
derivatives
processes
preparation
systems
Prior art date
Application number
IL16059902A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL160599A0 publication Critical patent/IL160599A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/20—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/17—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a ring other than a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16059902A 2001-08-31 2002-08-17 Derivatives of c2-substituted indan-1-ol systems, processes for their preparation and their use as pharmaceuticals IL160599A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10142662A DE10142662B4 (de) 2001-08-31 2001-08-31 Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
PCT/EP2002/009202 WO2003020694A1 (de) 2001-08-31 2002-08-17 Derivate von c2-substituierten indan-1-ol-systemen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
IL160599A0 true IL160599A0 (en) 2004-07-25

Family

ID=7697233

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16059902A IL160599A0 (en) 2001-08-31 2002-08-17 Derivatives of c2-substituted indan-1-ol systems, processes for their preparation and their use as pharmaceuticals

Country Status (12)

Country Link
US (1) US6717008B2 (xx)
EP (1) EP1425265B1 (xx)
JP (1) JP4263998B2 (xx)
AR (1) AR036774A1 (xx)
AT (1) ATE411979T1 (xx)
AU (1) AU2002333448B2 (xx)
CA (1) CA2458521A1 (xx)
DE (2) DE10142662B4 (xx)
IL (1) IL160599A0 (xx)
MX (1) MXPA04001855A (xx)
PE (1) PE20030339A1 (xx)
WO (1) WO2003020694A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142660A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142659A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142666A1 (de) * 2001-08-31 2003-03-20 Aventis Pharma Gmbh Verwendung von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE10142663B4 (de) 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-ol-Systeme
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
US9613547B2 (en) 2015-04-03 2017-04-04 Nastar Inc. Dual-faced labelling systems
US11551583B2 (en) 2020-07-27 2023-01-10 Nastar Inc. Separation of individual labels from dual-faced labeling systems

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2201882B1 (xx) * 1972-07-20 1975-10-31 Logeais Labor Jacques
GB1465794A (en) * 1974-05-17 1977-03-02 Wyeth John & Brother Ltd Thiourea derivatives
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
EP0009554B1 (de) 1978-07-27 1983-04-27 Schering Aktiengesellschaft Indanyl-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
EP0874800B1 (en) * 1995-12-06 2003-08-06 Venantius Limited Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
WO1997026265A1 (en) 1996-01-17 1997-07-24 Novo Nordisk A/S Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
DE122009000079I2 (de) 1996-08-30 2011-06-16 Novo Nordisk As Novo Alle Glp-1 derivate
DK0958296T3 (da) 1996-12-31 2003-08-18 Reddys Lab Ltd Dr Heterocykliske forbindelser, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem, og deres anvendelse i behandlingen af diabetes og beslægtede sygdomme
KR20010021936A (ko) 1997-07-16 2001-03-15 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
FR2769312B1 (fr) * 1997-10-03 1999-12-03 Adir Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2782515B1 (fr) * 1998-08-21 2000-09-22 Adir NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity

Also Published As

Publication number Publication date
PE20030339A1 (es) 2003-05-22
DE50212938D1 (de) 2008-12-04
EP1425265A1 (de) 2004-06-09
JP4263998B2 (ja) 2009-05-13
DE10142662B4 (de) 2004-07-08
JP2005525296A (ja) 2005-08-25
AU2002333448B2 (en) 2007-08-23
MXPA04001855A (es) 2004-06-15
WO2003020694A1 (de) 2003-03-13
US6717008B2 (en) 2004-04-06
DE10142662A1 (de) 2003-03-27
CA2458521A1 (en) 2003-03-13
ATE411979T1 (de) 2008-11-15
US20030105331A1 (en) 2003-06-05
AR036774A1 (es) 2004-10-06
EP1425265B1 (de) 2008-10-22

Similar Documents

Publication Publication Date Title
AU2002365516A1 (en) Benzamide derivatives, processes for their preparation, and their pharmaceutical use
IL158784A (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, processes for their preparation and pharmaceutical compositions containing them
ZA200403682B (en) N-adamantylmethyl derivatives and intermediates as pharmaceutical composition and processes for their preparation.
HUP0401718A3 (en) Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them
HK1070053A1 (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
AU2002233463A1 (en) Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
EE200300327A (et) Uurea derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutiline kompositsioon
HK1068336A1 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
AU2002356513A1 (en) Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers
MXPA03006478A (es) Derivados de cromano, procedimiento para su preparacion y su uso como agentes antitumorales.
HUP0401018A3 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0401369A3 (en) Pharmaceutical formulation comprising (r)-bicalutamide, process for its preparation and use thereof
IL160599A0 (en) Derivatives of c2-substituted indan-1-ol systems, processes for their preparation and their use as pharmaceuticals
AU2003257456A1 (en) Preparation of supported catalyst systems
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
AU2002333448A1 (en) Derivatives of C2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
IL160606A0 (en) C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals
HUP0304065A2 (hu) Új 5-tio-béta-D-xilopiranozid-származékok, eljárás előállításukra, ilyen vegyületeket tartalmazó gyógyászati kompozíciók és alkalmazásuk
AU2002229870A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
DK1157014T3 (da) Polycykliske 2-amino-dihydrothiazolsystemer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
IL160608A0 (en) C2-substituted indan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals
IL160938A0 (en) Coniosulphides and their derivatives, processes for preparing them, and their use as pharmaceuticals
IL159561A0 (en) Eurotinones and derivatives thereof, processes for preparing them, and their use
AU2002336982A1 (en) C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments
GB0109384D0 (en) Pharmaceutical products, preparation and uses thereof